Personalis Total Current Assets 2018-2024 | PSNL
Personalis total current assets from 2018 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
Personalis Annual Total Current Assets (Millions of US $) |
2023 |
$147 |
2022 |
$200 |
2021 |
$318 |
2020 |
$221 |
2019 |
$140 |
2018 |
$30 |
2017 |
$ |
Personalis Quarterly Total Current Assets (Millions of US $) |
2024-09-30 |
$170 |
2024-06-30 |
$113 |
2024-03-31 |
$120 |
2023-12-31 |
$147 |
2023-09-30 |
$148 |
2023-06-30 |
$161 |
2023-03-31 |
$183 |
2022-12-31 |
$200 |
2022-09-30 |
$222 |
2022-06-30 |
$260 |
2022-03-31 |
$294 |
2021-12-31 |
$318 |
2021-09-30 |
$329 |
2021-06-30 |
$354 |
2021-03-31 |
$373 |
2020-12-31 |
$221 |
2020-09-30 |
$224 |
2020-06-30 |
$120 |
2020-03-31 |
$135 |
2019-12-31 |
$140 |
2019-09-30 |
$140 |
2019-06-30 |
$176 |
2019-03-31 |
|
2018-12-31 |
|
2018-09-30 |
|
2018-06-30 |
|
2017-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.239B |
$0.073B |
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|